Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 258,568 |
|
|||||
| News | - | ||||||
| Day High | 995.405 | Low High |
|||||
| Day Low | 983.00 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc | REGN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 4.45 | 0.45% | 985.02 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 984.04 | 983.00 | 995.405 | 985.02 | 980.57 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 13,457 | 258,568 | US$ 988.20 | US$ 255,517,161 | - | 684.805 - 998.325 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:32:41 | 2 | US$ 985.03 | USD |
Regeneron Pharmaceuticals (REGN) Options Flow Summary
Regeneron Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 108.12B | 109.76M | - | 13.12B | 3.95B | 36.02 | 27.35 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Regeneron Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical REGN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 969.27 | 997.87 | 966.00 | 985.55 | 330,255 | 15.75 | 1.62% |
| 1 Month | 881.72 | 997.87 | 875.225 | 949.70 | 436,917 | 103.30 | 11.72% |
| 3 Months | 967.50 | 997.87 | 875.225 | 944.45 | 436,972 | 17.52 | 1.81% |
| 6 Months | 800.14 | 998.325 | 792.57 | 919.70 | 506,376 | 184.88 | 23.11% |
| 1 Year | 750.32 | 998.325 | 684.805 | 846.72 | 518,696 | 234.70 | 31.28% |
| 3 Years | 509.74 | 998.325 | 492.13 | 710.08 | 639,718 | 475.28 | 93.24% |
| 5 Years | 316.66 | 998.325 | 271.37 | 590.79 | 763,438 | 668.36 | 211.07% |
Regeneron Pharmaceuticals Description
| Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer, and bispecific antibodies and antibody cocktails with other collaborators and independently. |
